318 related articles for article (PubMed ID: 17922453)
1. ["Terzo fuoco", lead poisoning and chronic renal failure].
Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
[TBL] [Abstract][Full Text] [Related]
3. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
Lin JL; Lin-Tan DT; Hsu KH; Yu CC
N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
[TBL] [Abstract][Full Text] [Related]
4. Low-level environmental exposure to lead and progressive chronic kidney diseases.
Lin JL; Lin-Tan DT; Li YJ; Chen KH; Huang YL
Am J Med; 2006 Aug; 119(8):707.e1-9. PubMed ID: 16887418
[TBL] [Abstract][Full Text] [Related]
5. [Case of lead nephropathy due to chronic occupational lead exposure].
Ogata A; Sueta S; Tagawa M
Nihon Jinzo Gakkai Shi; 2011; 53(2):207-11. PubMed ID: 21516708
[TBL] [Abstract][Full Text] [Related]
6. Chronic lead poisoning: a "forgotten" cause of renal disease.
Benjelloun M; Tarrass F; Hachim K; Medkouri G; Benghanem MG; Ramdani B
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):83-6. PubMed ID: 17237897
[TBL] [Abstract][Full Text] [Related]
7. [Acute renal failure in the course of occupational lead intoxication. Chelation therapy responsability (author's transl)].
Yver L; Maréchaud R; Picaud D; Touchard G; d'Eyzac AT; Matuchansky C; Patte D
Nouv Presse Med; 1978 May; 7(18):1541-3. PubMed ID: 97624
[TBL] [Abstract][Full Text] [Related]
8. Occult lead intoxication as a cause of hypertension and renal failure.
Sánchez-Fructuoso AI; Torralbo A; Arroyo M; Luque M; Ruilope LM; Santos JL; Cruceyra A; Barrientos A
Nephrol Dial Transplant; 1996 Sep; 11(9):1775-80. PubMed ID: 8918621
[TBL] [Abstract][Full Text] [Related]
9. [Chronic nephropathy in saturnism. Comparative elimination of lead by classic chelating agents and peritoneal dialysis].
Mirouze J; Mion C; Mathieu-Daude P; Monnier L; Selam JL
Nouv Presse Med; 1975 May; 4(22):1642-4. PubMed ID: 1215179
[TBL] [Abstract][Full Text] [Related]
10. Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning.
Sánchez-Fructuoso AI; Cano M; Arroyo M; Fernández C; Prats D; Barrientos A
Am J Kidney Dis; 2002 Jul; 40(1):51-8. PubMed ID: 12087561
[TBL] [Abstract][Full Text] [Related]
11. Environmental lead exposure and chronic renal disease.
Elinder CG; Alvestrand A
N Engl J Med; 2003 May; 348(18):1810-2; author reply 1810-2. PubMed ID: 12728912
[No Abstract] [Full Text] [Related]
12. Combined exchange transfusion and chelation therapy for neonatal lead poisoning.
Mycyk MB; Leikin JB
Ann Pharmacother; 2004 May; 38(5):821-4. PubMed ID: 15026564
[TBL] [Abstract][Full Text] [Related]
13. Effect of chelation therapy on progressive diabetic nephropathy in patients with type 2 diabetes and high-normal body lead burdens.
Chen KH; Lin JL; Lin-Tan DT; Hsu HH; Hsu CW; Hsu KH; Yen TH
Am J Kidney Dis; 2012 Oct; 60(4):530-8. PubMed ID: 22721929
[TBL] [Abstract][Full Text] [Related]
14. Increased body lead burden--cause or consequence of chronic renal insufficiency?
Marsden PA
N Engl J Med; 2003 Jan; 348(4):345-7. PubMed ID: 12540649
[No Abstract] [Full Text] [Related]
15. Managing end-stage renal disease.
J Occup Med; 1991 May; 33(5):584. PubMed ID: 1908008
[No Abstract] [Full Text] [Related]
16. Failure of chelation therapy in lead nephropathy.
Germain MJ; Braden GL; Fitzgibbons JP
Arch Intern Med; 1984 Dec; 144(12):2419-20. PubMed ID: 6439141
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity.
Roels HA; Hoet P; Lison D
Ren Fail; 1999; 21(3-4):251-62. PubMed ID: 10416202
[TBL] [Abstract][Full Text] [Related]
18. Detection and treatment of occupational lead nephropathy.
Wedeen RP; Malik DK; Batuman V
Arch Intern Med; 1979 Jan; 139(1):53-7. PubMed ID: 760684
[TBL] [Abstract][Full Text] [Related]
19. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A
Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562
[TBL] [Abstract][Full Text] [Related]
20. Environmental lead exposure and chronic renal disease.
Owda AK; Alam MG; Shah SV
N Engl J Med; 2003 May; 348(18):1810-2; author reply 1810-2. PubMed ID: 12724490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
